Work

P-035 Real world experience of patients treated with teclistamab: a BCMA-directed bispecific T-cell engaging therapy for multiple myeloma

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01653-1

Authors: Shonali Midha, Houry Leblebjian, Jacob Laubach, Clifton Mo, Adam Sperling, Omar Nadeem, Giada Bianchi, Monique Hartley-Brown, Linda Ramsdell, Kristen Donadio, Emerald Chun, Megan Belanger, Irina Dobrusin, Irene Ghobrial, Paul Richardson, Kenneth Anderson, Nikhil Munshi

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387004037

Cites:

Cited by: 2

Related to: 10